I find dissenting viewpoints a far more interesting and valuable resource than sycophantic agreement. Far more can be learned through dissent than blind acceptance. Given that it is very difficult to find alternate viewpoints that contradict the groupthink doublespeak versions available from major media outlets and governmental agencies, I have gathered some online resources here.
Inclusion on the list below is not an endorsement. I don’t necessarily agree with everything any individual or organization presents on their website but I’m willing to let you make adult decisions and do your own research on any points that concern you.
- Swiss Policy Research founded in 2016, it is an independent, nonpartisan and nonprofit research group investigating geopolitical propaganda in Swiss and international media. SPR is composed of independent academics and receives no external funding. (source)
- The Ethical Skeptic Many find this site to constitute a hard read. Technical and legal writing constitutes a significant portion of my trade/businesses. I can often be found crafting agreements or specifications, documents which are by their intent precise and effective; not inane prose by any stretch. One should not attempt to casually speed-read or glean through this material and then pretend that their shortfall in mental effort now somehow translates into my responsibility. (source)
- Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers The recommendation to wear surgical masks to supplement other public health measures did not reduce the SARS-CoV-2 infection rate among wearers by more than 50% in a community with modest infection rates, some degree of social distancing, and uncommon general mask use. The data were compatible with lesser degrees of self-protection.
Editorial by Me
- The so-called vaccines are gene therapies not vaccines.
COVID-19 Vaccine Candidates Show Gene Therapy is a Viable Strategy These findings, announced by Moderna on Nov. 16 and by Pfizer and its partner BioNTech on Nov. 9, demonstrate that gene therapy is a viable strategy for developing vaccines to combat COVID-19. Both vaccine candidates use mRNA to program a person’s cells to produce many copies of a fragment of the virus. The fragment then stimulates the immune system to attack if the real virus tries to invade the body.